Literature DB >> 27003147

Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change?

Flaviano S Martins1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27003147     DOI： 10.1007/s10620-016-4133-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.

Authors:  S D A Elian; E L S Souza; A T Vieira; M M Teixeira; R M E Arantes; J R Nicoli; F S Martins
Journal:  Benef Microbes       Date:  2015       Impact factor: 4.205

2.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.

Authors:  B EISEMAN; W SILEN; G S BASCOM; A J KAUVAR
Journal:  Surgery       Date:  1958-11       Impact factor: 3.982

3.  Should we standardize the 1,700-year-old fecal microbiota transplantation?

Authors:  Faming Zhang; Wensheng Luo; Yan Shi; Zhining Fan; Guozhong Ji
Journal:  Am J Gastroenterol       Date:  2012-11       Impact factor: 10.864

4.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.

Authors:  Éricka L Souza; Samir D Elian; Laís M Paula; Cristiana C Garcia; Angélica T Vieira; Mauro M Teixeira; Rosa M Arantes; Jacques R Nicoli; Flaviano S Martins
Journal:  J Med Microbiol       Date:  2016-01-12       Impact factor: 2.472

Review 5.  Fecal microbiota transplantation in treating Clostridium difficile infection.

Authors:  William R Brown
Journal:  J Dig Dis       Date:  2014-08       Impact factor: 2.325

6.  Immunopathogenesis of inflammatory bowel disease.

Authors:  Julien Matricon; Nicolas Barnich; Denis Ardid
Journal:  Self Nonself       Date:  2010-10

7.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Authors:  Paul Moayyedi; Michael G Surette; Peter T Kim; Josie Libertucci; Melanie Wolfe; Catherine Onischi; David Armstrong; John K Marshall; Zain Kassam; Walter Reinisch; Christine H Lee
Journal:  Gastroenterology       Date:  2015-04-07       Impact factor: 22.682

8.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

9.  Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease.

Authors:  F C P Tiago; B A A Porto; N S Ribeiro; L M C Moreira; R M E Arantes; A T Vieira; M M Teixeira; S V Generoso; V N Nascimento; F S Martins; J R Nicoli
Journal:  Benef Microbes       Date:  2015-08-31       Impact factor: 4.205

Review 10.  Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.

Authors:  Yezaz A Ghouri; David M Richards; Erik F Rahimi; Joseph T Krill; Katherine A Jelinek; Andrew W DuPont
Journal:  Clin Exp Gastroenterol       Date:  2014-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.